Monthly
US$200
Billed every month
Sign in to subscribeLactulose Oral Solution
As of 13 November 2026, for Lactulose Oral Solution, 34 applications are listed as under review at China's CDE; 9 companies have filed new generic applications in 2026; the chemical-drug catalogue lists 1 holder.
Companies, stages and changes, with each record available on this page.
Last 90 days: Accepted: 14 applicationsNo longer listed under review: 6 applicationsSupplement delivery: 6 applications
Current coverage may be incomplete
US Orange Book listing
The brand names come from the US FDA Orange Book and describe US listing records for this active ingredient. They do not indicate that products under these brand names are approved or sold in China, or that Chinese applicants are affiliated with US holders.
Orange Book source export date: 2026/11/06. Version: 2026-11-06.
Showing 2 of 2 distinct brand names.
A brand with different source forms or statuses can appear on multiple rows and in both groups. Distinct brand names are counted once globally, with a limit of five.
Verified official English dosage form: Oral Solution. Listings are grouped by the source dosage form and route; records without a clear correspondence are listed in the other group. Grouping does not establish product equivalence.
Same dosage form
| Brand name | Applicant (source text) | Application number | Dosage form (source text) | Route (source text) | Marketing status (source text) | Approval date |
|---|---|---|---|---|---|---|
| CHRONULAC | SANOFI AVENTIS US LLC | NDA 017884 · Product no. 001 | SOLUTION | ORAL | DISCONTINUED | Approved prior to 1982 (exact date not listed) |
Other dosage forms of the same ingredient
| Brand name | Applicant (source text) | Application number | Dosage form (source text) | Route (source text) | Marketing status (source text) | Approval date |
|---|---|---|---|---|---|---|
| CEPHULAC | SANOFI AVENTIS US LLC | NDA 017657 · Product no. 001 | SOLUTION | ORAL, RECTAL | DISCONTINUED | Approved prior to 1982 (exact date not listed) |
Same-form/route listings come first, followed by other forms/routes. Within each group, source prescription/OTC listings precede discontinued listings; unknown statuses are last. Each status bucket is ordered by earliest approval date, ascending: pre-1982 records first, missing dates last; ties by brand name, application number and product number. The first five distinct brands in this order are selected globally. All retained source facts for those brands are shown in their own groups; a brand spanning both groups counts once.
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.
Catalogue holders1View records ↓
Under-review filings34View records ↓
This year’s generic filers9View records ↓
NHSA approval numbers112View records ↓
API companies with A status1View records ↓
Chemical-drug catalogue
Loaded records: 1 holders; 0 in the quality-and-efficacy consistency-evaluation category, and 0 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Abbott Healthcare Products B.V. | Abbott Biologicals B.V. | H20171057 | 1996/06/25 | 667mg/ml | Imported originator drug | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 112 distinct approval numbers and 67 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| Hunan Qian Jin Xiang Jiang Pharma Co., Ltd. romanized | 国药准字H20264429 | 200ml:133.4g | Category B | XA06ADR050X001010104960 | NHSA |
| Jiangxi Hai Er Si Pharma Co., Ltd. romanized | 国药准字H20263062 | 15ml:10g | Category B | XA06ADR050X001010105291 | NHSA |
| Jiangxi Sheng Xiang Pharmaceutical Co., Ltd. romanized | 国药准字H20265144 | 15ml:10g | Category B | XA06ADR050X001010105355 | NHSA |
| Zhejiang Yuan Li Jian Pharma Co., Ltd. romanized | 国药准字H20263202 | 15ml:10g | Category B | XA06ADR050X001010109207 | NHSA |
| Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | 国药准字H20263084 | 15ml:10g | Category B | XA06ADR050X001010180537 | NHSA |
| Shandong Chen Xin Fu Dou Pharma Co., Ltd. romanized | 国药准字H20264746 | 15ml:10g | Category B | XA06ADR050X001010183191 | NHSA |
| Ling Yao Bio Technology (Shanghai) Co., Ltd. romanized | 国药准字H20265379 | 200ml:133.4g | Category B | XA06ADR050X001010183356 | NHSA |
| Jiangsu Guang Cheng Pharma Co., Ltd. romanized | 国药准字H20263308 | 100ml :66.7g | Category B | XA06ADR050X001010183611 | NHSA |
| Guangzhou Hu Rui Pharmaceuticals Technology Development Co., Ltd. romanized | 国药准字H20263599 | 15ml:10g | Category B | XA06ADR050X001010183642 | NHSA |
| Henan He Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20264134 | 200ml:133.4g | Category B | XA06ADR050X001010183926 | NHSA |
| Xi Zhou Pharmaceuticals Technology (Zhejiang) Co., Ltd. romanized | 国药准字H20263762 | 15ml:10g | Category B | XA06ADR050X001010184209 | NHSA |
| Fujian Sheng Rong Heng Pharmaceuticals Co., Ltd. romanized | 国药准字H20265345 | 100ml:66.7g | Category B | XA06ADR050X001010184977 | NHSA |
| Jiangxi Sheng Xiang Pharmaceutical Co., Ltd. romanized | 国药准字H20265144 | 15ml:10g | Category B | XA06ADR050X001010205355 | NHSA |
| Zhejiang Yuan Li Jian Pharma Co., Ltd. romanized | 国药准字H20263202 | 15ml:10g | Category B | XA06ADR050X001010209207 | NHSA |
| Shandong Chen Xin Fu Dou Pharma Co., Ltd. romanized | 国药准字H20264746 | 15ml:10g | Category B | XA06ADR050X001010283191 | NHSA |
| Xi Zhou Pharmaceuticals Technology (Zhejiang) Co., Ltd. romanized | 国药准字H20263762 | 15ml:10g | Category B | XA06ADR050X001010284209 | NHSA |
| Jiangxi Sheng Xiang Pharmaceutical Co., Ltd. romanized | 国药准字H20265144 | 15ml:10g | Category B | XA06ADR050X001010305355 | NHSA |
| Shandong Chen Xin Fu Dou Pharma Co., Ltd. romanized | 国药准字H20264746 | 15ml:10g | Category B | XA06ADR050X001010383191 | NHSA |
| Jiangxi Sheng Xiang Pharmaceutical Co., Ltd. romanized | 国药准字H20265144 | 15ml:10g | Category B | XA06ADR050X001010405355 | NHSA |
| Shandong Chen Xin Fu Dou Pharma Co., Ltd. romanized | 国药准字H20264746 | 15ml:10g | Category B | XA06ADR050X001010483191 | NHSA |
| Jiangxi Sheng Xiang Pharmaceutical Co., Ltd. romanized | 国药准字H20265144 | 15ml:10g | Category B | XA06ADR050X001010505355 | NHSA |
| Shandong Chen Xin Fu Dou Pharma Co., Ltd. romanized | 国药准字H20264746 | 15ml:10g | Category B | XA06ADR050X001010583191 | NHSA |
| Jiangxi Sheng Xiang Pharmaceutical Co., Ltd. romanized | 国药准字H20265144 | 15ml:10g | Category B | XA06ADR050X001010605355 | NHSA |
| Shandong Chen Xin Fu Dou Pharma Co., Ltd. romanized | 国药准字H20264746 | 15ml:10g | Category B | XA06ADR050X001010683191 | NHSA |
| Jiangxi Sheng Xiang Pharmaceutical Co., Ltd. romanized | 国药准字H20265144 | 15ml:10g | Category B | XA06ADR050X001010705355 | NHSA |
| Shandong Chen Xin Fu Dou Pharma Co., Ltd. romanized | 国药准字H20264746 | 15ml:10g | Category B | XA06ADR050X001010783191 | NHSA |
| Jiangxi Sheng Xiang Pharmaceutical Co., Ltd. romanized | 国药准字H20265144 | 15ml:10g | Category B | XA06ADR050X001010805355 | NHSA |
| Shandong Chen Xin Fu Dou Pharma Co., Ltd. romanized | 国药准字H20264746 | 15ml:10g | Category B | XA06ADR050X001010883191 | NHSA |
| Shandong Chen Xin Fu Dou Pharma Co., Ltd. romanized | 国药准字H20264746 | 15ml:10g | Category B | XA06ADR050X001010983191 | NHSA |
| Shandong Chen Xin Fu Dou Pharma Co., Ltd. romanized | 国药准字H20264746 | 15ml:10g | Category B | XA06ADR050X001011083191 | NHSA |
| Shandong Chen Xin Fu Dou Pharma Co., Ltd. romanized | 国药准字H20264746 | 15ml:10g | Category B | XA06ADR050X001011183191 | NHSA |
| Jiangxi Hai Er Si Pharma Co., Ltd. romanized | 国药准字H20263063 | 200ml:133.4g | Category B | XA06ADR050X001020105291 | NHSA |
| Jiangxi Sheng Xiang Pharmaceutical Co., Ltd. romanized | 国药准字H20265145 | 200ml:133.4g | Category B | XA06ADR050X001020105355 | NHSA |
| Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | 国药准字H20263084 | 15ml:10g | Category B | XA06ADR050X001020180537 | NHSA |
| Ling Yao Bio Technology (Shanghai) Co., Ltd. romanized | 国药准字H20265378 | 15ml: 10g | Category B | XA06ADR050X001020183356 | NHSA |
| Chongqing He Ping Pharmaceutical Co., Ltd. romanized | 国药准字H20263307 | 15ml:10g | Category B | XA06ADR050X001030101001 | NHSA |
| Shaanxi Xing Bang Pharma Co., Ltd. romanized | 国药准字H20264284 | 200ml:133.4g | Category B | XA06ADR050X001030102471 | NHSA |
| Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20263102 | 5ml:3.3g | Category B | XA06ADR050X001030183595 | NHSA |
| Chongqing He Ping Pharmaceutical Co., Ltd. romanized | 国药准字H20263307 | 15ml:10g | Category B | XA06ADR050X001030201001 | NHSA |
| Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20263102 | 5ml:3.3g | Category B | XA06ADR050X001030283595 | NHSA |
| Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20263102 | 5ml:3.3g | Category B | XA06ADR050X001030383595 | NHSA |
| Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20263102 | 5ml:3.3g | Category B | XA06ADR050X001030483595 | NHSA |
| Shaanxi Xing Bang Pharma Co., Ltd. romanized | 国药准字H20264285 | 5ml:3.3g | Category B | XA06ADR050X001040102471 | NHSA |
| Shaanxi Xing Bang Pharma Co., Ltd. romanized | 国药准字H20264286 | 100ml:66.7g | Category B | XA06ADR050X001050102471 | NHSA |
| Shaanxi Xing Bang Pharma Co., Ltd. romanized | 国药准字H20264287 | 15ml:10g | Category B | XA06ADR050X001060102471 | NHSA |
| Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20269132 | 100ml:66.7g | Category B | XA06ADR050X001060180651 | NHSA |
| Chongqing He Ping Pharmaceutical Co., Ltd. romanized | 国药准字H20256361 | 200ml:133.4g | Category B | XA06ADR050X001010101001 | NHSA |
| Mei Luo Pharma Co., Ltd. romanized | 国药准字H20258288 | 200ml:133.4g | Category B | XA06ADR050X001010101122 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20256407 | 15ml:10g | Category B | XA06ADR050X001010101503 | NHSA |
| Yun Peng Pharmaceuticals Group Co., Ltd. romanized | 国药准字H20253657 | 15ml:10g | Category B | XA06ADR050X001010102968 | NHSA |
| Ha Yao Group Zhong Yao Er Factory romanized | 国药准字H20253805 | 15mL:10g | Category B | XA06ADR050X001010103714 | NHSA |
| Jewim Pharmaceutical (Shandong) Co., Ltd. | 国药准字H20253157 | 15ml:10g | Category B | XA06ADR050X001010104111 | NHSA |
| Guo Yao Holding Xing Sha Pharmaceutical (Xiamen) Co., Ltd. romanized | 国药准字H20255372 | 15ml:10g | Category B | XA06ADR050X001010104873 | NHSA |
| Guangxi Wei Wei Pharmaceutical Co., Ltd. romanized | 国药准字H20255429 | 15ml:10g | Category B | XA06ADR050X001010105237 | NHSA |
| Chengdu Bei Te De Nuo Pharma Co., Ltd. romanized | 国药准字H20254757 | 5ml:3.3g | Category B | XA06ADR050X001010182338 | NHSA |
| Jinan Kang Qiao Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253347 | 200ml:133.4g | Category B | XA06ADR050X001010183056 | NHSA |
| Qingdao Ge En Pharmaceutical Co., Ltd. romanized | 国药准字H20253484 | 15ml:10g | Category B | XA06ADR050X001010183584 | NHSA |
| Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20255546 | 15ml:10g | Category B | XA06ADR050X001010183595 | NHSA |
| Chongqing Jian Neng Pharma Group Co., Ltd. romanized | 国药准字H20253369 | 100ml:66.7g | Category B | XA06ADR050X001010183692 | NHSA |
| Le Fu Si Health Industry Shareholding Company romanized | 国药准字H20254718 | 15ml:10g | Category B | XA06ADR050X001010183955 | NHSA |
| Guo Yao Group Zhi Jun (Shenzhen) Ping Shan Pharmaceutical Co., Ltd. romanized | 国药准字H20253075 | 15ml:10g | Category B | XA06ADR050X001010184482 | NHSA |
| Hubei Mei Si Chuang Pharma Co., Ltd. romanized | 国药准字H20253366 | 100ml:66.7g | Category B | XA06ADR050X001010184577 | NHSA |
| Beijing Han Mei Bio Technology Co., Ltd. romanized | 国药准字H20253514 | 100ml:66.7g | Category B | XA06ADR050X001010184761 | NHSA |
| Chongqing Shi Yi Li Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20254719 | 100ml:66.7g | Category B | XA06ADR050X001010184778 | NHSA |
| Hunan Ji Zheng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20255714 | 15ml:10g | Category B | XA06ADR050X001010184994 | NHSA |
| Jiangxi Yuan Chao Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20255383 | 15ml:10g | Category B | XA06ADR050X001010185010 | NHSA |
| Chengdu Ke Lai Meng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20255718 | 200ml:133.4g | Category B | XA06ADR050X001010185240 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20256407 | 15ml:10g | Category B | XA06ADR050X001010201503 | NHSA |
| Yun Peng Pharmaceuticals Group Co., Ltd. romanized | 国药准字H20253657 | 15ml:10g | Category B | XA06ADR050X001010202968 | NHSA |
| Jewim Pharmaceutical (Shandong) Co., Ltd. | 国药准字H20253157 | 15ml:10g | Category B | XA06ADR050X001010204111 | NHSA |
| Guangxi Wei Wei Pharmaceutical Co., Ltd. romanized | 国药准字H20255429 | 15ml:10g | Category B | XA06ADR050X001010205237 | NHSA |
| Chengdu Bei Te De Nuo Pharma Co., Ltd. romanized | 国药准字H20254757 | 5ml:3.3g | Category B | XA06ADR050X001010282338 | NHSA |
| Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20255546 | 15ml:10g | Category B | XA06ADR050X001010283595 | NHSA |
| Le Fu Si Health Industry Shareholding Company romanized | 国药准字H20254718 | 15ml:10g | Category B | XA06ADR050X001010283955 | NHSA |
| Guo Yao Group Zhi Jun (Shenzhen) Ping Shan Pharmaceutical Co., Ltd. romanized | 国药准字H20253075 | 15ml:10g | Category B | XA06ADR050X001010284482 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20256407 | 15ml:10g | Category B | XA06ADR050X001010301503 | NHSA |
| Yun Peng Pharmaceuticals Group Co., Ltd. romanized | 国药准字H20253657 | 15ml:10g | Category B | XA06ADR050X001010302968 | NHSA |
| Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20255546 | 15ml:10g | Category B | XA06ADR050X001010383595 | NHSA |
| Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20255546 | 15ml:10g | Category B | XA06ADR050X001010483595 | NHSA |
| Chongqing He Ping Pharmaceutical Co., Ltd. romanized | 国药准字H20256360 | 100ml:66.7g | Category B | XA06ADR050X001020101001 | NHSA |
| Mei Luo Pharma Co., Ltd. romanized | 国药准字H20253985 | 100ml: 66.7g | Category B | XA06ADR050X001020101122 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20256408 | 200ml:133.4g | Category B | XA06ADR050X001020101503 | NHSA |
| Ha Yao Group Zhong Yao Er Factory romanized | 国药准字H20253805 | 15mL:10g | Category B | XA06ADR050X001020103714 | NHSA |
| Guo Yao Holding Xing Sha Pharmaceutical (Xiamen) Co., Ltd. romanized | 国药准字H20255373 | 200ml:133.4g | Category B | XA06ADR050X001020104873 | NHSA |
| Guangxi Wei Wei Pharmaceutical Co., Ltd. romanized | 国药准字H20255430 | 200ml:133.4g | Category B | XA06ADR050X001020105237 | NHSA |
| Chengdu Bei Te De Nuo Pharma Co., Ltd. romanized | 国药准字H20254758 | 200ml:133.4g | Category B | XA06ADR050X001020182338 | NHSA |
| Jinan Kang Qiao Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253348 | 100ml:66.7g | Category B | XA06ADR050X001020183056 | NHSA |
| Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20255546 | 15ml:10g | Category B | XA06ADR050X001020183595 | NHSA |
| Chongqing Jian Neng Pharma Group Co., Ltd. romanized | 国药准字H20253370 | 15ml:10g | Category B | XA06ADR050X001020183692 | NHSA |
| Beijing Han Mei Bio Technology Co., Ltd. romanized | 国药准字H20254035 | 15ml:10g | Category B | XA06ADR050X001020184761 | NHSA |
| Chongqing Shi Yi Li Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20254720 | 200ml:133.4g | Category B | XA06ADR050X001020184778 | NHSA |
| Hunan Ji Zheng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20255715 | 200ml:133.4g | Category B | XA06ADR050X001020184994 | NHSA |
| Jiangxi Yuan Chao Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20255382 | 200ml:133.4g | Category B | XA06ADR050X001020185010 | NHSA |
| Chengdu Ke Lai Meng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20255719 | 15ml:10g | Category B | XA06ADR050X001020185240 | NHSA |
| Mei Luo Pharma Co., Ltd. romanized | 国药准字H20258287 | 5ml:3.3g | Category B | XA06ADR050X001030101122 | NHSA |
| Beijing Cheng Ji Pharmaceutical Co., Ltd. romanized | 国药准字H20258290 | 60ml:40.02g | Category B | XA06ADR050X001030182209 | NHSA |
| Jinan Kang Qiao Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253349 | 15ml:10g | Category B | XA06ADR050X001030183056 | NHSA |
| Hunan Ji Zheng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20255714 | 15ml:10g | Category B | XA06ADR050X001030184994 | NHSA |
| Jinan Kang Qiao Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253349 | 15ml:10g | Category B | XA06ADR050X001030283056 | NHSA |
| Mei Luo Pharma Co., Ltd. romanized | 国药准字H20258286 | 15ml:10g | Category B | XA06ADR050X001040101122 | NHSA |
| Beijing Cheng Ji Pharmaceutical Co., Ltd. romanized | 国药准字H20258291 | 100ml:66.7g | Category B | XA06ADR050X001040182209 | NHSA |
| Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20253168 | 200ml:133.4g | Category B | XA06ADR050X001050180651 | NHSA |
| Beijing Han Mei Medicines Co., Ltd. romanized | 国药准字H20065730 | 100ml:66.7g | Category B | XA06ADR050X001010100041 | NHSA |
| Da Lian Mei Luo Zhong Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20093299 | 10ml:5g | Category B | XA06ADR050X001010101123 | NHSA |
| Dan Dong Kang Fu Pharmaceutical Co., Ltd. romanized | 国药准字H10890057 | 50% | Category B | XA06ADR050X001010101150 | NHSA |
| Jian Min Pharma Group Co., Ltd. romanized | 国药准字H20244664 | 200ml:133.4g | Category B | XA06ADR050X001010101946 | NHSA |
| Sichuan Jian Neng Pharmaceutical Co., Ltd. romanized | 国药准字H20103621 | 60ml:40.02g | Category B | XA06ADR050X001010102166 | NHSA |
| Shaanxi Han Tang Pharmaceutical Co., Ltd. romanized | 国药准字H10890034 | 100ml:50g | Category B | XA06ADR050X001010102471 | NHSA |
| Shi Yao Yin Hu Pharmaceutical Co., Ltd. romanized | 国药准字H20249423 | 15ml:10g | Category B | XA06ADR050X001010102964 | NHSA |
| Heilongjiang Zhong Gui Pharmaceutical Co., Ltd. romanized | 国药准字H20249558 | 15ml:10g | Category B | XA06ADR050X001010103804 | NHSA |
| Qingdao Huang Hai Pharmaceutical Co., Ltd. romanized | 国药准字H20249749 | 15ml:10g | Category B | XA06ADR050X001010104043 | NHSA |
| Lai Yang Shi Jiang Bo Pharmaceutical Co., Ltd. romanized | 国药准字H20074009 | 10ml:5g | Category B | XA06ADR050X001010104201 | NHSA |
| Beijing Mai Kang Pharma Co., Ltd. romanized | 国药准字H20234275 | 200ml:133.4g | Category B | XA06ADR050X001010104948 | NHSA |
| Hunan Ke Lun Pharmaceutical Co., Ltd. romanized | 国药准字H20093523 | 100ml:66.7g | Category B | XA06ADR050X001010105006 | NHSA |
| Jiang You Pharmaceutical (Chang De) Co., Ltd. romanized | 国药准字H20249250 | 15ml:10g | Category B | XA06ADR050X001010105031 | NHSA |
| Hainan Si Da Pharmaceutical Co., Ltd. romanized | 国药准字H20249475 | 200ml:133.4g | Category B | XA06ADR050X001010105816 | NHSA |
| Fresenius Kabi Austria GmbH | H20160470 | 100ml:67g | Category B | XA06ADR050X001010178433 | NHSA |
| Abbott B.V. | 国药准字HJ20171057 | 667mg/ml | Category B | XA06ADR050X001010178890 | NHSA |
| Beijing Mai Kang Pharma Co., Ltd. romanized | 国药准字H20234273 | 15ml:10g | Category B | XA06ADR050X001010180528 | NHSA |
| Su Zhou Yi Fan Pharma Co., Ltd. romanized | 国药准字J20170046 | 100ml: 67g | Category B | XA06ADR050X001010180637 | NHSA |
| Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20243601 | 15ml:10g | Category B | XA06ADR050X001010180651 | NHSA |
| Sichuan De Feng Pharma Co., Ltd. romanized | 国药准字H20223553 | 667mg/mL(5ml:3.3g、15ml:10g、100ml:66.7g、200ml:133.4g) | Category B | XA06ADR050X001010181575 | NHSA |
| Beijing Cheng Ji Pharmaceutical Co., Ltd. romanized | 国药准字H20233728 | 667mg/ml(15ml:10g、200ml:133.4g) | Category B | XA06ADR050X001010182209 | NHSA |
| Hainan Wan Wei Pharmaceutical Co., Ltd. romanized | 国药准字H20249253 | 15ml:10g | Category B | XA06ADR050X001010182249 | NHSA |
| Bao Ding Ai Hui Pharma Co., Ltd. romanized | 国药准字H20249742 | 200ml:133.4g | Category B | XA06ADR050X001010182314 | NHSA |
| Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20249347 | 15ml:10g | Category B | XA06ADR050X001010183242 | NHSA |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | 国药准字H20243526 | 100ml:66.7g | Category B | XA06ADR050X001010183644 | NHSA |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | 国药准字H20249342 | 15ml:10g | Category B | XA06ADR050X001010183719 | NHSA |
| Jiangsu Yue Xing Pharma Co., Ltd. romanized | 国药准字H20249283 | 200ml:133.4g | Category B | XA06ADR050X001010183775 | NHSA |
| Hainan Mei Kang Da Pharma Co., Ltd. romanized | 国药准字H20243713 | 15ml:10g | Category B | XA06ADR050X001010183920 | NHSA |
| Chongqing Mai Chuan Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20249795 | 15ml:10g | Category B | XA06ADR050X001010184196 | NHSA |
| Hua Run Jiang Zhong Pharma Co., Ltd. romanized | 国药准字H20244227 | 15ml:10g | Category B | XA06ADR050X001010184211 | NHSA |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20244623 | 15ml:10g | Category B | XA06ADR050X001010184221 | NHSA |
| Jiangxi Dan Kang Pharmaceutical Co., Ltd. romanized | 国药准字H20244825 | 200ml:133.4g | Category B | XA06ADR050X001010184227 | NHSA |
| Hua Cui International Bio Technology (Guangdong) Co., Ltd. romanized | 国药准字H20249304 | 100ml:66.7g | Category B | XA06ADR050X001010184487 | NHSA |
| Beijing Fu Xin An Kang Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20244690 | 15ml:10g | Category B | XA06ADR050X001010184745 | NHSA |
| Da Lian Mei Luo Zhong Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20093299 | 10ml:5g | Category B | XA06ADR050X001010201123 | NHSA |
| Dan Dong Kang Fu Pharmaceutical Co., Ltd. romanized | 国药准字H10890057 | 50% | Category B | XA06ADR050X001010201150 | NHSA |
| Heilongjiang Zhong Gui Pharmaceutical Co., Ltd. romanized | 国药准字H20249558 | 15ml:10g | Category B | XA06ADR050X001010203804 | NHSA |
| Qingdao Huang Hai Pharmaceutical Co., Ltd. romanized | 国药准字H20249749 | 15ml:10g | Category B | XA06ADR050X001010204043 | NHSA |
| Jiang You Pharmaceutical (Chang De) Co., Ltd. romanized | 国药准字H20249250 | 15ml:10g | Category B | XA06ADR050X001010205031 | NHSA |
| Yunnan Kang Jian Shan Mei Pharmaceutical Co., Ltd. romanized | 国药准字H53020078 | 100ml:50g | Category B | XA06ADR050X001010205681 | NHSA |
| Beijing Mai Kang Pharma Co., Ltd. romanized | 国药准字H20234273 | 15ml:10g | Category B | XA06ADR050X001010280528 | NHSA |
| Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20243601 | 15ml:10g | Category B | XA06ADR050X001010280651 | NHSA |
| Sichuan De Feng Pharma Co., Ltd. romanized | 国药准字H20223553 | 667mg/mL(5ml:3.3g、15ml:10g、100ml:66.7g、200ml:133.4g) | Category B | XA06ADR050X001010281575 | NHSA |
| Beijing Cheng Ji Pharmaceutical Co., Ltd. romanized | 国药准字H20233728 | 667mg/ml(15ml:10g、200ml:133.4g) | Category B | XA06ADR050X001010282209 | NHSA |
| Hainan Wan Wei Pharmaceutical Co., Ltd. romanized | 国药准字H20249253 | 15ml:10g | Category B | XA06ADR050X001010282249 | NHSA |
| Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20249347 | 15ml:10g | Category B | XA06ADR050X001010283242 | NHSA |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | 国药准字H20249342 | 15ml:10g | Category B | XA06ADR050X001010283719 | NHSA |
| Chongqing Mai Chuan Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20249795 | 15ml:10g | Category B | XA06ADR050X001010284196 | NHSA |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20244623 | 15ml:10g | Category B | XA06ADR050X001010284221 | NHSA |
| Beijing Fu Xin An Kang Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20244690 | 15ml:10g | Category B | XA06ADR050X001010284745 | NHSA |
| Da Lian Mei Luo Zhong Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20093299 | 10ml:5g | Category B | XA06ADR050X001010301123 | NHSA |
| Dan Dong Kang Fu Pharmaceutical Co., Ltd. romanized | 国药准字H10890057 | 50% | Category B | XA06ADR050X001010301150 | NHSA |
| Qingdao Huang Hai Pharmaceutical Co., Ltd. romanized | 国药准字H20249749 | 15ml:10g | Category B | XA06ADR050X001010304043 | NHSA |
| Jiang You Pharmaceutical (Chang De) Co., Ltd. romanized | 国药准字H20249250 | 15ml:10g | Category B | XA06ADR050X001010305031 | NHSA |
| Beijing Mai Kang Pharma Co., Ltd. romanized | 国药准字H20234273 | 15ml:10g | Category B | XA06ADR050X001010380528 | NHSA |
| Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20243601 | 15ml:10g | Category B | XA06ADR050X001010380651 | NHSA |
| Sichuan De Feng Pharma Co., Ltd. romanized | 国药准字H20223553 | 667mg/mL(5ml:3.3g、15ml:10g、100ml:66.7g、200ml:133.4g) | Category B | XA06ADR050X001010381575 | NHSA |
| Beijing Cheng Ji Pharmaceutical Co., Ltd. romanized | 国药准字H20233728 | 667mg/ml(15ml:10g、200ml:133.4g) | Category B | XA06ADR050X001010382209 | NHSA |
| Hainan Wan Wei Pharmaceutical Co., Ltd. romanized | 国药准字H20249253 | 15ml:10g | Category B | XA06ADR050X001010382249 | NHSA |
| Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20249347 | 15ml:10g | Category B | XA06ADR050X001010383242 | NHSA |
| Beijing Fu Xin An Kang Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20244690 | 15ml:10g | Category B | XA06ADR050X001010384745 | NHSA |
| Da Lian Mei Luo Zhong Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20093299 | 10ml:5g | Category B | XA06ADR050X001010401123 | NHSA |
| Dan Dong Kang Fu Pharmaceutical Co., Ltd. romanized | 国药准字H10890057 | 50% | Category B | XA06ADR050X001010401150 | NHSA |
| Qingdao Huang Hai Pharmaceutical Co., Ltd. romanized | 国药准字H20249749 | 15ml:10g | Category B | XA06ADR050X001010404043 | NHSA |
| Jiang You Pharmaceutical (Chang De) Co., Ltd. romanized | 国药准字H20249250 | 15ml:10g | Category B | XA06ADR050X001010405031 | NHSA |
| Beijing Mai Kang Pharma Co., Ltd. romanized | 国药准字H20234273 | 15ml:10g | Category B | XA06ADR050X001010480528 | NHSA |
| Sichuan De Feng Pharma Co., Ltd. romanized | 国药准字H20223553 | 667mg/mL(5ml:3.3g、15ml:10g、100ml:66.7g、200ml:133.4g) | Category B | XA06ADR050X001010481575 | NHSA |
| Beijing Cheng Ji Pharmaceutical Co., Ltd. romanized | 国药准字H20233728 | 667mg/ml(15ml:10g、200ml:133.4g) | Category B | XA06ADR050X001010482209 | NHSA |
| Hainan Wan Wei Pharmaceutical Co., Ltd. romanized | 国药准字H20249253 | 15ml:10g | Category B | XA06ADR050X001010482249 | NHSA |
| Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20249347 | 15ml:10g | Category B | XA06ADR050X001010483242 | NHSA |
| Da Lian Mei Luo Zhong Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20093299 | 10ml:5g | Category B | XA06ADR050X001010501123 | NHSA |
| Qingdao Huang Hai Pharmaceutical Co., Ltd. romanized | 国药准字H20249749 | 15ml:10g | Category B | XA06ADR050X001010504043 | NHSA |
| Jiang You Pharmaceutical (Chang De) Co., Ltd. romanized | 国药准字H20249250 | 15ml:10g | Category B | XA06ADR050X001010505031 | NHSA |
| Beijing Mai Kang Pharma Co., Ltd. romanized | 国药准字H20234273 | 15ml:10g | Category B | XA06ADR050X001010580528 | NHSA |
| Sichuan De Feng Pharma Co., Ltd. romanized | 国药准字H20223553 | 667mg/mL(5ml:3.3g、15ml:10g、100ml:66.7g、200ml:133.4g) | Category B | XA06ADR050X001010581575 | NHSA |
| Beijing Cheng Ji Pharmaceutical Co., Ltd. romanized | 国药准字H20233728 | 667mg/ml(15ml:10g、200ml:133.4g) | Category B | XA06ADR050X001010582209 | NHSA |
| Hainan Wan Wei Pharmaceutical Co., Ltd. romanized | 国药准字H20249253 | 15ml:10g | Category B | XA06ADR050X001010582249 | NHSA |
| Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20249347 | 15ml:10g | Category B | XA06ADR050X001010583242 | NHSA |
| Da Lian Mei Luo Zhong Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20093299 | 10ml:5g | Category B | XA06ADR050X001010601123 | NHSA |
| Qingdao Huang Hai Pharmaceutical Co., Ltd. romanized | 国药准字H20249749 | 15ml:10g | Category B | XA06ADR050X001010604043 | NHSA |
| Beijing Mai Kang Pharma Co., Ltd. romanized | 国药准字H20234273 | 15ml:10g | Category B | XA06ADR050X001010680528 | NHSA |
| Sichuan De Feng Pharma Co., Ltd. romanized | 国药准字H20223553 | 667mg/mL(5ml:3.3g、15ml:10g、100ml:66.7g、200ml:133.4g) | Category B | XA06ADR050X001010681575 | NHSA |
| Hainan Wan Wei Pharmaceutical Co., Ltd. romanized | 国药准字H20249253 | 15ml:10g | Category B | XA06ADR050X001010682249 | NHSA |
| Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20249347 | 15ml:10g | Category B | XA06ADR050X001010683242 | NHSA |
| Da Lian Mei Luo Zhong Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20093299 | 10ml:5g | Category B | XA06ADR050X001010701123 | NHSA |
| Beijing Mai Kang Pharma Co., Ltd. romanized | 国药准字H20234273 | 15ml:10g | Category B | XA06ADR050X001010780528 | NHSA |
| Beijing Han Mei Medicines Co., Ltd. romanized | 国药准字H20065730 | 100ml:66.7g | Category B | XA06ADR050X001020100041 | NHSA |
| Da Lian Mei Luo Zhong Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20093300 | 100ml:50g | Category B | XA06ADR050X001020101123 | NHSA |
| Dan Dong Kang Fu Pharmaceutical Co., Ltd. romanized | 国药准字H10890057 | 50% | Category B | XA06ADR050X001020101150 | NHSA |
| Sichuan Jian Neng Pharmaceutical Co., Ltd. romanized | 国药准字H20103621 | 60ml:40.02g | Category B | XA06ADR050X001020102166 | NHSA |
| Shaanxi Han Tang Pharmaceutical Co., Ltd. romanized | 国药准字H10890034 | 100ml:50g | Category B | XA06ADR050X001020102471 | NHSA |
| Qingdao Huang Hai Pharmaceutical Co., Ltd. romanized | 国药准字H20249750 | 100ml:66.7g | Category B | XA06ADR050X001020104043 | NHSA |
| Lai Yang Shi Jiang Bo Pharmaceutical Co., Ltd. romanized | 国药准字H20074010 | 100ml:50g | Category B | XA06ADR050X001020104201 | NHSA |
| Hunan Ke Lun Pharmaceutical Co., Ltd. romanized | 国药准字H20093524 | 250ml:166.8g | Category B | XA06ADR050X001020105006 | NHSA |
| Fresenius Kabi Austria GmbH | H20160470 | 100ml:67g | Category B | XA06ADR050X001020178433 | NHSA |
| Abbott B.V. | 国药准字HJ20171057 | 667mg/ml | Category B | XA06ADR050X001020178890 | NHSA |
| Beijing Mai Kang Pharma Co., Ltd. romanized | 国药准字H20234274 | 100ml:66.7g | Category B | XA06ADR050X001020180528 | NHSA |
| Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20243601 | 15ml:10g | Category B | XA06ADR050X001020180651 | NHSA |
| Sichuan De Feng Pharma Co., Ltd. romanized | 国药准字H20223553 | 667mg/mL(5ml:3.3g、15ml:10g、100ml:66.7g、200ml:133.4g) | Category B | XA06ADR050X001020181575 | NHSA |
| Beijing Cheng Ji Pharmaceutical Co., Ltd. romanized | 国药准字H20233728 | 667mg/ml(15ml:10g、200ml:133.4g) | Category B | XA06ADR050X001020182209 | NHSA |
| Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20249348 | 200ml:133.4g | Category B | XA06ADR050X001020183242 | NHSA |
| Hainan Mei Kang Da Pharma Co., Ltd. romanized | 国药准字H20243714 | 100ml:66.7g | Category B | XA06ADR050X001020183920 | NHSA |
| Chongqing Mai Chuan Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20249796 | 5ml:3.3g | Category B | XA06ADR050X001020184196 | NHSA |
| Hua Run Jiang Zhong Pharma Co., Ltd. romanized | 国药准字H20244228 | 200ml:133.4g | Category B | XA06ADR050X001020184211 | NHSA |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20244624 | 200ml:133.4g | Category B | XA06ADR050X001020184221 | NHSA |
| Jiangxi Dan Kang Pharmaceutical Co., Ltd. romanized | 国药准字H20244824 | 15ml:10g | Category B | XA06ADR050X001020184227 | NHSA |
| Beijing Fu Xin An Kang Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20244690 | 15ml:10g | Category B | XA06ADR050X001020184745 | NHSA |
| Sichuan De Feng Pharma Co., Ltd. romanized | 国药准字H20223553 | 667mg/mL(5ml:3.3g、15ml:10g、100ml:66.7g、200ml:133.4g) | Category B | XA06ADR050X001020281575 | NHSA |
| Jiangxi Dan Kang Pharmaceutical Co., Ltd. romanized | 国药准字H20244824 | 15ml:10g | Category B | XA06ADR050X001020284227 | NHSA |
| Beijing Fu Xin An Kang Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20244690 | 15ml:10g | Category B | XA06ADR050X001020284745 | NHSA |
| Jiangxi Dan Kang Pharmaceutical Co., Ltd. romanized | 国药准字H20244824 | 15ml:10g | Category B | XA06ADR050X001020384227 | NHSA |
| Beijing Fu Xin An Kang Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20244690 | 15ml:10g | Category B | XA06ADR050X001020384745 | NHSA |
| Jiangxi Dan Kang Pharmaceutical Co., Ltd. romanized | 国药准字H20244824 | 15ml:10g | Category B | XA06ADR050X001020484227 | NHSA |
| Beijing Fu Xin An Kang Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20244690 | 15ml:10g | Category B | XA06ADR050X001020484745 | NHSA |
| Beijing Han Mei Medicines Co., Ltd. romanized | 国药准字H20065730 | 100ml:66.7g | Category B | XA06ADR050X001030100041 | NHSA |
| Da Lian Mei Luo Zhong Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20093299 | 10ml:5g | Category B | XA06ADR050X001030101123 | NHSA |
| Sichuan Jian Neng Pharmaceutical Co., Ltd. romanized | 国药准字H20103621 | 60ml:40.02g | Category B | XA06ADR050X001030102166 | NHSA |
| Lai Yang Shi Jiang Bo Pharmaceutical Co., Ltd. romanized | 国药准字H20074009 | 10ml:5g | Category B | XA06ADR050X001030104201 | NHSA |
| Fresenius Kabi Austria GmbH | 国药准字HJ20170152 | 15ml:10g | Category B | XA06ADR050X001030178433 | NHSA |
| Abbott B.V. | 国药准字HJ20171057 | 667mg/ml | Category B | XA06ADR050X001030178890 | NHSA |
| Beijing Mai Kang Pharma Co., Ltd. romanized | 国药准字H20234273 | 15ml:10g | Category B | XA06ADR050X001030180528 | NHSA |
| Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20243601 | 15ml:10g | Category B | XA06ADR050X001030180651 | NHSA |
| Sichuan De Feng Pharma Co., Ltd. romanized | 国药准字H20223553 | 667mg/mL(5ml:3.3g、15ml:10g、100ml:66.7g、200ml:133.4g) | Category B | XA06ADR050X001030181575 | NHSA |
| Hua Run Jiang Zhong Pharma Co., Ltd. romanized | 国药准字H20244227 | 15ml:10g | Category B | XA06ADR050X001030184211 | NHSA |
| Jiangxi Dan Kang Pharmaceutical Co., Ltd. romanized | 国药准字H20244824 | 15ml:10g | Category B | XA06ADR050X001030184227 | NHSA |
| Da Lian Mei Luo Zhong Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20093299 | 10ml:5g | Category B | XA06ADR050X001030201123 | NHSA |
| Fresenius Kabi Austria GmbH | 国药准字HJ20170152 | 15ml:10g | Category B | XA06ADR050X001030278433 | NHSA |
| Abbott B.V. | 国药准字HJ20171057 | 667mg/ml | Category B | XA06ADR050X001030278890 | NHSA |
| Beijing Mai Kang Pharma Co., Ltd. romanized | 国药准字H20234273 | 15ml:10g | Category B | XA06ADR050X001030280528 | NHSA |
| Jiangxi Dan Kang Pharmaceutical Co., Ltd. romanized | 国药准字H20244824 | 15ml:10g | Category B | XA06ADR050X001030284227 | NHSA |
| Da Lian Mei Luo Zhong Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20093299 | 10ml:5g | Category B | XA06ADR050X001030301123 | NHSA |
| Beijing Mai Kang Pharma Co., Ltd. romanized | 国药准字H20234273 | 15ml:10g | Category B | XA06ADR050X001030380528 | NHSA |
| Jiangxi Dan Kang Pharmaceutical Co., Ltd. romanized | 国药准字H20244824 | 15ml:10g | Category B | XA06ADR050X001030384227 | NHSA |
| Da Lian Mei Luo Zhong Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20093299 | 10ml:5g | Category B | XA06ADR050X001030401123 | NHSA |
| Da Lian Mei Luo Zhong Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20093299 | 10ml:5g | Category B | XA06ADR050X001030501123 | NHSA |
| Da Lian Mei Luo Zhong Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20093299 | 10ml:5g | Category B | XA06ADR050X001030601123 | NHSA |
| Beijing Han Mei Medicines Co., Ltd. romanized | 国药准字H20065730 | 100ml:66.7g | Category B | XA06ADR050X001040100041 | NHSA |
| Da Lian Mei Luo Zhong Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20093300 | 100ml:50g | Category B | XA06ADR050X001040101123 | NHSA |
| Fresenius Kabi Austria GmbH | 国药准字HJ20170248 | 100ml:67g | Category B | XA06ADR050X001040178433 | NHSA |
| Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20243601 | 15ml:10g | Category B | XA06ADR050X001040180651 | NHSA |
| Fresenius Kabi Austria GmbH | 国药准字HJ20160470 | 100ml:67g | Category B | XA06ADR050X001050178433 | NHSA |
| Fresenius Kabi Austria GmbH | 国药准字HJ20160470 | 100ml:67g | Category B | XA06ADR050X001050278433 | NHSA |
| Fujian Sheng Rong Heng Pharmaceuticals Co., Ltd. romanized | 国药准字H20264457 | 15ml:10g | Category B | XA06ADR050X001020184977 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 34 filings and 23 distinct first applicants.
Generic 29 · Supplement 5
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Shandong Lu Kang San Ye Pharmaceutical Co., Ltd. romanized; Lai Yang Shi Jiang Bo Pharmaceutical Co., Ltd. romanized | CYHS2600520 | Generic | 2026/02/25 | Not stated by source | CDE |
| Shijiazhuang Kai Da Bio Gong Cheng Co., Ltd. romanized; Le Sheng Pharma Shijiazhuang Co., Ltd. romanized | CYHS2602064 | Generic | 2026/08/20 | Not stated by source | CDE |
| Shijiazhuang Kai Da Bio Gong Cheng Co., Ltd. romanized; Le Sheng Pharma Shijiazhuang Co., Ltd. romanized | CYHS2602063 | Generic | 2026/08/20 | Not stated by source | CDE |
| Jiangsu Yue Xing Pharma Co., Ltd. romanized | CYHB2501371 | Supplement | 2025/07/10 | Not stated by source | CDE |
| Jiangsu Shen Hua Pharma Co., Ltd. romanized | CYHS2504208 | Generic | 2025/12/06 | Not stated by source | CDE |
| Jiangsu Chen Pai Bang De Pharma Co., Ltd. romanized | CYHS2504268 | Generic | 2025/12/12 | Not stated by source | CDE |
| Hainan Si Da Pharmaceutical Co., Ltd. romanized | CYHB2601906 | Supplement | 2026/10/19 | Not stated by source | CDE |
| Hainan Si Da Pharmaceutical Co., Ltd. romanized | CYHB2601905 | Supplement | 2026/10/19 | Not stated by source | CDE |
| Chengdu Pusch Pharmaceutical Co., Ltd. | CYHS2602265 | Generic | 2026/09/10 | Not stated by source | CDE |
| Hebei Hua Chen Pharma Group Co., Ltd. romanized | CYHS2602186 | Generic | 2026/09/02 | Not stated by source | CDE |
| Hebei Hua Chen Pharma Group Co., Ltd. romanized | CYHS2602185 | Generic | 2026/09/02 | Not stated by source | CDE |
| Zhejiang Guo Jing Pharma Co., Ltd. romanized | CYHS2601987 | Generic | 2026/08/13 | Not stated by source | CDE |
| Jiangxi Shimei Pharmaceutical Co., Ltd | CYHS2601959 | Generic | 2026/08/10 | Not stated by source | CDE |
| Zhejiang Mei Di Shen Biopharmaceuticals Co., Ltd. romanized; Zhejiang Kai Run Pharma Co., Ltd. romanized | CYHS2601547 | Generic | 2026/07/01 | Not stated by source | CDE |
| Zhejiang Mei Di Shen Biopharmaceuticals Co., Ltd. romanized; Zhejiang Kai Run Pharma Co., Ltd. romanized | CYHS2601546 | Generic | 2026/07/01 | Not stated by source | CDE |
| Hubei Mei Si Chuang Pharma Co., Ltd. romanized | CYHB2601115 | Supplement | 2026/06/12 | Not stated by source | CDE |
| Hubei Mei Si Chuang Pharma Co., Ltd. romanized | CYHB2601108 | Supplement | 2026/06/12 | Not stated by source | CDE |
| Henan Ling Rui Pharmaceutical Co., Ltd. romanized | CYHS2600646 | Generic | 2026/03/12 | Not stated by source | CDE |
| Zhejiang Jin Li Yuan Pharma Co., Ltd. romanized | CYHS2600322 | Generic | 2026/01/31 | Not stated by source | CDE |
| Jiangxi Di Sai Nuo Pharmaceuticals Group Co., Ltd. romanized; Chi Feng Yuan Sheng Pharma Co., Ltd. romanized | CYHS2504252 | Generic | 2025/12/11 | Not stated by source | CDE |
| Jiangxi Di Sai Nuo Pharmaceuticals Group Co., Ltd. romanized; Chi Feng Yuan Sheng Pharma Co., Ltd. romanized | CYHS2504251 | Generic | 2025/12/11 | Not stated by source | CDE |
| Jiangxi Di Sai Nuo Pharmaceuticals Group Co., Ltd. romanized; Chi Feng Yuan Sheng Pharma Co., Ltd. romanized | CYHS2504250 | Generic | 2025/12/11 | Not stated by source | CDE |
| Jiangxi Yao Dou Ren He Pharmaceutical Co., Ltd. romanized | CYHS2503984 | Generic | 2025/11/18 | Not stated by source | CDE |
| Tianjin He Zhi Pharma Group Co., Ltd. romanized | CYHS2503347 | Generic | 2025/09/10 | Not stated by source | CDE |
| Tianjin He Zhi Pharma Group Co., Ltd. romanized | CYHS2503346 | Generic | 2025/09/10 | Not stated by source | CDE |
| Zhejiang Zhen Yuan Pharmaceutical Co., Ltd. romanized | CYHS2502985 | Generic | 2025/08/15 | Not stated by source | CDE |
| Zhejiang Zhen Yuan Pharmaceutical Co., Ltd. romanized | CYHS2502984 | Generic | 2025/08/15 | Not stated by source | CDE |
| Zhejiang Zhen Yuan Pharmaceutical Co., Ltd. romanized | CYHS2502982 | Generic | 2025/08/15 | Not stated by source | CDE |
| Zhejiang Kang En Bei Pharmaceutical Co., Ltd. romanized | CYHS2502896 | Generic | 2025/08/09 | Not stated by source | CDE |
| Zhejiang Kang En Bei Pharmaceutical Co., Ltd. romanized | CYHS2502895 | Generic | 2025/08/09 | Not stated by source | CDE |
| Wuhan An Cheng Pharmaceuticals Co., Ltd. romanized; Hubei Ji An Tang Pharma Co., Ltd. romanized | CYHS2501838 | Generic | 2025/05/22 | Not stated by source | CDE |
| Beijing Jin Dian Han Fang Pharma Co., Ltd. romanized | CYHS2501558 | Generic | 2025/04/25 | Not stated by source | CDE |
| Henan Tai Feng Bio Technology Co., Ltd. romanized | CYHS2501451 | Generic | 2025/04/16 | Not stated by source | CDE |
| Hubei Wu Shi Pharma Co., Ltd. romanized | CYHS2501168 | Generic | 2025/03/25 | Not stated by source | CDE |
New generic filings in 2026
Loaded records: 12 filings and 9 distinct first applicants.
API registrations
Non-component matches: 1 companies with A status and 0 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 乳果糖 · No verified English name | Fresenius Kabi Austria GmbH | Y20170001096 | A | Exact ingredient | 2025/10/15 | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/13 06:39. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
This source was last successfully updated at 2026/11/12 18:32; current coverage may be incomplete.
-
2026/11/11No longer listed under review
Jiangxi Dan Kang Pharmaceutical Co., Ltd. romanized
CYHB2601564
Fact date: 2026/11/11 · Site observation date: 2026/11/11
Accepted: 2026/08/17
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/11/10 (approval no.: —; approval date: 2026/11/09); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 20
NMPA · Table row 20 ↗ View source ↗ -
2026/11/11No longer listed under review
Hunan Ke Lun Pharmaceutical Co., Ltd. romanized
CYHB2600092
Fact date: 2026/11/11 · Site observation date: 2026/11/11
Accepted: 2026/01/17
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/11/10 (approval no.: —; approval date: 2026/11/09); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 10
NMPA · Table row 10 ↗ View source ↗ -
2026/11/09Supplement delivery
Jiangxi Dan Kang Pharmaceutical Co., Ltd. romanized
CYHB2601564
Fact date: 2026/11/09 · Publication date: 2026/11/10 · Site observation date: 2026/11/10
Supplemental application; excluded from new marketing approvals.
View source · Table row 20 ↗ -
2026/11/09Supplement delivery
Hunan Ke Lun Pharmaceutical Co., Ltd. romanized
CYHB2600092
Fact date: 2026/11/09 · Publication date: 2026/11/10 · Site observation date: 2026/11/10
Supplemental application; excluded from new marketing approvals.
View source · Table row 10 ↗ -
2026/11/07No longer listed under review
Ya Bang Pharmaceuticals Co., Ltd. romanized; Shaanxi Han Tang Pharmaceutical Co., Ltd. romanized
CYHB2601876
Fact date: 2026/11/07 · Site observation date: 2026/11/07
Accepted: 2026/10/13
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/11/06 (approval no.: —; approval date: 2026/11/05); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 34
NMPA · Table row 34 ↗ View source ↗ -
2026/11/07No longer listed under review
Ya Bang Pharmaceuticals Co., Ltd. romanized; Shaanxi Han Tang Pharmaceutical Co., Ltd. romanized
CYHB2601875
Fact date: 2026/11/07 · Site observation date: 2026/11/07
Accepted: 2026/10/13
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/11/06 (approval no.: —; approval date: 2026/11/05); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 33
NMPA · Table row 33 ↗ View source ↗ -
2026/11/07No longer listed under review
Ya Bang Pharmaceuticals Co., Ltd. romanized; Shaanxi Han Tang Pharmaceutical Co., Ltd. romanized
CYHB2601874
Fact date: 2026/11/07 · Site observation date: 2026/11/07
Accepted: 2026/10/13
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/11/06 (approval no.: —; approval date: 2026/11/05); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 32
NMPA · Table row 32 ↗ View source ↗ -
2026/11/07No longer listed under review
Ya Bang Pharmaceuticals Co., Ltd. romanized; Shaanxi Han Tang Pharmaceutical Co., Ltd. romanized
CYHB2601873
Fact date: 2026/11/07 · Site observation date: 2026/11/07
Accepted: 2026/10/13
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/11/06 (approval no.: —; approval date: 2026/11/05); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 31
NMPA · Table row 31 ↗ View source ↗ -
2026/11/05Supplement delivery
Ya Bang Pharmaceuticals Co., Ltd. romanized
CYHB2601876
Fact date: 2026/11/05 · Publication date: 2026/11/06 · Site observation date: 2026/11/06
Supplemental application; excluded from new marketing approvals.
View source · Table row 34 ↗ -
2026/11/05Supplement delivery
Ya Bang Pharmaceuticals Co., Ltd. romanized
CYHB2601875
Fact date: 2026/11/05 · Publication date: 2026/11/06 · Site observation date: 2026/11/06
Supplemental application; excluded from new marketing approvals.
View source · Table row 33 ↗ -
2026/11/05Supplement delivery
Ya Bang Pharmaceuticals Co., Ltd. romanized
CYHB2601874
Fact date: 2026/11/05 · Publication date: 2026/11/06 · Site observation date: 2026/11/06
Supplemental application; excluded from new marketing approvals.
View source · Table row 32 ↗ -
2026/11/05Supplement delivery
Ya Bang Pharmaceuticals Co., Ltd. romanized
CYHB2601873
Fact date: 2026/11/05 · Publication date: 2026/11/06 · Site observation date: 2026/11/06
Supplemental application; excluded from new marketing approvals.
View source · Table row 31 ↗ -
2026/10/19Accepted
Hainan Si Da Pharmaceutical Co., Ltd. romanized
CYHB2601906
Fact date: 2026/10/19 · Site observation date: 2026/10/22
View source ↗ -
2026/10/19Accepted
Hainan Si Da Pharmaceutical Co., Ltd. romanized
CYHB2601905
Fact date: 2026/10/19 · Site observation date: 2026/10/22
View source ↗ -
2026/10/13Accepted
Ya Bang Pharmaceuticals Co., Ltd. romanized; Shaanxi Han Tang Pharmaceutical Co., Ltd. romanized
CYHB2601876
Fact date: 2026/10/13 · Site observation date: 2026/10/22
View source ↗ -
2026/10/13Accepted
Ya Bang Pharmaceuticals Co., Ltd. romanized; Shaanxi Han Tang Pharmaceutical Co., Ltd. romanized
CYHB2601875
Fact date: 2026/10/13 · Site observation date: 2026/10/22
View source ↗ -
2026/10/13Accepted
Ya Bang Pharmaceuticals Co., Ltd. romanized; Shaanxi Han Tang Pharmaceutical Co., Ltd. romanized
CYHB2601874
Fact date: 2026/10/13 · Site observation date: 2026/10/22
View source ↗ -
2026/10/13Accepted
Ya Bang Pharmaceuticals Co., Ltd. romanized; Shaanxi Han Tang Pharmaceutical Co., Ltd. romanized
CYHB2601873
Fact date: 2026/10/13 · Site observation date: 2026/10/22
View source ↗ -
2026/09/17Accepted
Lian Huan Pharma (An Qing) Co., Ltd. romanized; Jiangsu Lianhuan Pharmaceutical Co.,Ltd.
CYHB2601757
Fact date: 2026/09/17 · Site observation date: 2026/10/21
View source ↗ -
2026/09/17Accepted
Lian Huan Pharma (An Qing) Co., Ltd. romanized; Jiangsu Lianhuan Pharmaceutical Co.,Ltd.
CYHB2601756
Fact date: 2026/09/17 · Site observation date: 2026/10/21
View source ↗ -
2026/09/10Accepted
Chengdu Pusch Pharmaceutical Co., Ltd.
CYHS2602265
Fact date: 2026/09/10 · Site observation date: 2026/10/22
View source ↗ -
2026/09/02Accepted
Hebei Hua Chen Pharma Group Co., Ltd. romanized
CYHS2602186
Fact date: 2026/09/02 · Site observation date: 2026/10/22
View source ↗ -
2026/09/02Accepted
Hebei Hua Chen Pharma Group Co., Ltd. romanized
CYHS2602185
Fact date: 2026/09/02 · Site observation date: 2026/10/22
View source ↗ -
2026/08/20Accepted
Shijiazhuang Kai Da Bio Gong Cheng Co., Ltd. romanized; Le Sheng Pharma Shijiazhuang Co., Ltd. romanized
CYHS2602064
Fact date: 2026/08/20 · Site observation date: 2026/10/21
View source ↗ -
2026/08/20Accepted
Shijiazhuang Kai Da Bio Gong Cheng Co., Ltd. romanized; Le Sheng Pharma Shijiazhuang Co., Ltd. romanized
CYHS2602063
Fact date: 2026/08/20 · Site observation date: 2026/10/21
View source ↗ -
2026/08/17Accepted
Jiangxi Dan Kang Pharmaceutical Co., Ltd. romanized
CYHB2601564
Fact date: 2026/08/17 · Site observation date: 2026/10/22
View source ↗
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/13 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/13 06:39
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/13 06:41
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/12 18:32 · Current coverage may be incomplete
First index-page publication dates: 2026-10-29 to 2026-11-13; 2 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/13 08:09 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 7/30; discovered pending details: 13. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Lactulose Oral Solution
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Sign in to subscribeYearly
US$1,920
Billed every year
US$160 per month
Sign in to subscribeNeed more than 10 followed products or more than 5 recipients? Contact us.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
Billed by Creem, our merchant of record · Terms · Refund policy